Cadca

Cadca (Community Anti-Drug Coalitions of America), a non-profit organization headquartered in Alexandria, Virginia, delivers substance abuse prevention training, youth leadership development, community coalition capacity building, and drug-prevention outreach services to federal agencies as a prime contractor (99% of recent awards) and as a sub-recipient on grant programs. Cadca operates in the full-and-open federal market with no set-aside designations across its recent portfolio, competing primarily on established Blanket Purchase Agreements and purchase orders rather than reserved categories.

Cadca's federal customer concentration is heavily concentrated with the Department of Justice Drug Enforcement Administration, which accounts for 79 awards (combined potential value $7.2 million) and represents 59% of recent award volume tracked by the portfolio. The next tier of customers — the Department of State Bureau of International Narcotics Law Enforcement (19 awards), the Substance Abuse and Mental Health Services Administration (7 awards, $259 thousand), the Department of the Army (7 awards), and the Executive Office of the President Office of the National Drug Control Policy (6 awards) — collectively account for the remaining awards in the top-five customer set. By potential-value ranking, DEA dominates with $7.2 million, followed by the Centers for Disease Control and Prevention Pittsburgh ($777 thousand), the Air National Guard ($739 thousand), and the Justice Department's Office of Justice Programs ($515 thousand). The concentration against DEA is structural — Cadca holds a $2.5 million Blanket Purchase Agreement vehicle (15DDHQ20A00000008) with DEA that has generated 42 task orders, the largest single parent vehicle in the portfolio.

Recent representative work includes a $998 thousand purchase order from DEA awarded May 8, 2026 for the 2026 First National Fentanyl Free America Summit (community engagement and prevention), a $36.4 thousand BPA call from DEA for virtual youth leadership training (August 2024), a $215 thousand purchase order from CDC Pittsburgh for fiscal year 2023 programmatic activities (September 2023), and a $233.5 thousand purchase order from CDC Pittsburgh for Drug-Free Communities training and technical support (July 2021). Training-centered work is the dominant NAICS category: 56 awards fall under Professional and Management Development Training, 48 under Other Social Advocacy Organizations, and smaller volumes under consulting and general management support. Performance service codes track similarly, with 48 awards coded as Education/Training–Other and 25 as Support–Professional.

Cadca's grant footprint spans multiple federal grantor agencies and includes recipient and sub-recipient positions. The Executive Office of the President Office of the National Drug Control Policy awarded $2.5 million project grants in 2021 and 2022 to support the National Community Anti-Drug Coalition Institute (CFDA #95.003). The Substance Abuse and Mental Health Services Administration awarded a cooperative agreement with completion through September 2029 for the CADCA Coalitions Training program, supporting training and technical assistance to state and community prevention leaders. The National Center for Chronic Disease Prevention and Health Promotion awarded a cooperative agreement running through September 2028 for the Geographic Health Equity Alliance (GHEA) network, focused on tobacco control and health equity in rural areas. The Department of State Bureau of International Narcotics Law Enforcement has awarded multiple project grants totaling roughly $400 thousand for establishing anti-drug coalition networks in target countries including the Philippines, Pakistan, Ecuador, Uzbekistan, and the Dominican Republic. The National Highway Traffic Safety Administration awarded a cooperative agreement in November 2024 for developing resources to prevent impaired-driving crashes and injuries. Cadca also acts as a sub-recipient under a Missouri Department of Health & Senior Services grant (awarded May 2024) providing training and technical assistance for chronic disease prevention. As a sub-contractor, Cadca delivered outreach and communications support under ICF Incorporated for NIAAA 2024 National Leadership Forum support (December 2023 sub-award).

Activity has declined in recent years — sixteen awards in 2022, eighteen in 2023, fourteen in 2024, dropping to six in 2025 and one in 2026 — though the portfolio carries a combined obligated amount of $109.4 million against a combined potential value of $12.8 million, indicating substantial prior-year carryover and completion. Only two awards face ultimate completion within the next twenty-four months (combined potential value $1 million), presenting minimal recompete exposure in that window. Cadca maintains a named subsidiary, Cadcares Solutions LLC, structured as a for-profit limited liability company, though the source does not describe its operational role or market positioning. Cadca's non-profit status and exclusive focus on substance abuse prevention, community coalition development, and related training support positions it as a specialized provider within the federal prevention and health promotion space rather than as a broad IT, logistics, or general contractor.